Technology update: dissolvable microneedle patches for vaccine delivery

References

• Rodgers AM, Cordeiro AS, Kissenpfennig A, Donnelly RF. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity. Expert Opin Drug Deliv. 2018. doi:10.1080/17425247.2018.1505860
   Web of Science ®Google Scholar
• Nir Y, Paz A, Sabo E, Potasman I. Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg. 2003;68(3):341–344. doi:10.4269/ajtmh.2003.68.34112685642
   PubMed Web of Science ®Google Scholar
• Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine. 2012;30(32):4807–4812. doi:10.1016/j.vaccine.2012.05.01122617633
   PubMed Web of Science ®Google Scholar
• Arya JM, Prausnitz MR. Microneedle patches for vaccination in developing countries. J Control Release. 2016;240:135–141. doi:10.1016/j.jconrel.2015.11.01926603347
   PubMed Web of Science ®Google Scholar
• Kaufmann JR, Miller R, Cheyne J. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Aff. 2011;30(6):1113–1121. doi:10.1377/hlthaff.2011.0368
   PubMed Web of Science ®Google Scholar
• Ashok A, Brison M, LeTallec Y. Improving cold chain systems: challenges and solutions. Vaccine. 2017;35(17):2217–2223. doi:10.1016/j.vaccine.2016.08.04527670076
   PubMed Web of Science ®Google Scholar
• Baicus A. History of polio vaccination. World J Virol. 2012;1(4):108. doi:10.5501/wjv.v1.i4.10824175215
   PubMedGoogle Scholar
• Bandyopadhyay AS, Garon J, Seib K, Orenstein WA. Polio vaccination: past, present and future. Future Microbiol. 2015;10(5):791–808. doi:10.2217/fmb.15.1925824845
   PubMed Web of Science ®Google Scholar
• Davitt CJ, Lavelle EC. Delivery strategies to enhance oral vaccination against enteric infections. Adv Drug Deliv Rev. 2015;91:52–69. doi:10.1016/j.addr.2015.03.00725817337
   PubMed Web of Science ®Google Scholar
• Rodgers AM, McCrudden MT, Vincente-Perez EM, et al. Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: a proof of concept study. Int J Pharm. 2018;549(1–2):87–95. doi:10.1016/j.ijpharm.2018.07.04930048778
   PubMed Web of Science ®Google Scholar
• Du G, Hathout RM, Nasr M, et al. Intradermal vaccination with hollow microneedles: a comparative study of various protein antigen and adjuvant encapsulated nanoparticles. J Control Release. 2017;266:109–118. doi:10.1016/j.jconrel.2017.09.02128943194
   PubMed Web of Science ®Google Scholar
• Depelsenaire AC, Meliga SC, McNeilly CL, et al. Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol. 2014;134(9):2361–2370. doi:10.1038/jid.2014.17424714201
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, Martin M, del P, et al. Transdermal influenza immunization with vaccine-coated microneedle arrays. Unutmaz D, ed. PLoS One. 2009;4(3):e4773. doi:10.1371/journal.pone.000477319274084
   PubMed Web of Science ®Google Scholar
• Courtenay AJ, Rodgers AM, McCrudden MT, McCarthy HO, Donnelly RF. Novel hydrogel-forming microneedle array for intradermal vaccination in mice using ovalbumin as a model protein antigen. Mol Pharm. 2019;16(1):118–127. doi:10.1021/acs.molpharmaceut.8b0089530452868
   PubMed Web of Science ®Google Scholar
• Vrdoljak A, Allen EA, Ferrara F, Temperton NJ, Crean AM, Moore AC. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods. J Control Release. 2016;225:192–204. doi:10.1016/j.jconrel.2016.01.01926774221
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang Q-B, Liu B, et al. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant. Int J Nanomedicine. 2017;12:4763–4772. doi:10.2147/IJN.S13245628740383
   PubMed Web of Science ®Google Scholar
• González-Vázquez P, Larrañeta E, McCrudden MT, et al. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis. J Control Release. 2017;265:30–40. doi:10.1016/j.jconrel.2017.07.03228754611
   PubMed Web of Science ®Google Scholar
• Rouphael NG, Paine M, Mosley R, et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017;390(10095):649–658. doi:10.1016/S0140-6736(17)30575-528666680
   PubMed Web of Science ®Google Scholar
• Ono A, Ito S, Sakagami S, et al. Development of novel faster-dissolving microneedle patches for transcutaneous vaccine delivery. Pharmaceutics. 2017;9(4):27. doi:10.3390/pharmaceutics9030027
   Web of Science ®Google Scholar
• Ripolin A, Quinn J, Larrañeta E, Vicente-Perez EM, Barry JG, Donnelly RF. Successful application of large microneedle patches by human volunteers. Int J Pharm. 2017;521(1–2):92–101. doi:10.1016/j.ijpharm.2017.02.01128216463
   PubMed Web of Science ®Google Scholar
• Lee I-C, Lin W-M-M, Shu J-C-C, Tsai S-W-W, Chen C-H-H, Tsai M-T-T. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice. J Biomed Mater Res - Part A. 2017;105(1):84–93. doi:10.1002/jbm.a.35869
   PubMed Web of Science ®Google Scholar
• Chen H, Wu B, Zhang M, et al. A novel scalable fabrication process for the production of dissolving microneedle arrays. Drug Deliv Transl Res. 2019;9(1):240–248. doi:10.1007/s13346-018-00593-z30341765
   PubMed Web of Science ®Google Scholar
• Nejad HR, Sadeqi A, Kiaee G, Sonkusale S. Low-cost and cleanroom-free fabrication of microneedles. Microsyst Nanoeng. 2018;4(1):17073. doi:10.1038/micronano.2017.73
   Web of Science ®Google Scholar
• Rodgers AM, Courtenay AJ, Donnelly RF. Dissolving microneedles for intradermal vaccination: manufacture, formulation, and stakeholder considerations. Expert Opin Drug Deliv. 2018;15(11):1039–1043. doi:10.1080/17425247.2018.152230130204003
   PubMed Web of Science ®Google Scholar
• Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Annu Rev Chem Biomol Eng. 2017;8(1):9.1–9.24. doi:10.1146/annurev-chembioeng-060816-101514
   Web of Science ®Google Scholar
• Kim Y-C, Prausnitz MR. Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res. 2011;1(1):7–12. doi:10.1007/s13346-010-0005-z21799951
   PubMed Web of Science ®Google Scholar
• Hegde NR, Kaveri SV, Bayry J. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discov Today. 2011;16(23–24):1061–1068. doi:10.1016/J.DRUDIS.2011.07.00421782969
   PubMed Web of Science ®Google Scholar
• Zaric M, Lyubomska O, Touzelet O, et al. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D, L-Lactide-Co-Glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano. 2013;7(3):2042–2055. doi:10.1021/nn304235j23373658
   PubMed Web of Science ®Google Scholar
• Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med. 2000;6(12):1403–1406. doi:10.1038/8222511100128
   PubMed Web of Science ®Google Scholar
• Güereña-Burgueño F, Hall ER, Taylor DN, et al. Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect Immun. 2002;70(4):1874–1880. doi:10.1128/IAI.70.4.187411895950
   PubMed Web of Science ®Google Scholar
• McKenzie R, Bourgeois AL, Frech SA, et al. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. Vaccine. 2007;25(18):3684–3691. doi:10.1016/j.vaccine.2007.01.04317313998
   PubMed Web of Science ®Google Scholar
• Frech SA, Dupont HL, Bourgeois AL, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008;371(9629):2019–2025. doi:10.1016/S0140-6736(08)60839-918554712
   PubMed Web of Science ®Google Scholar
• Combadière B, Vogt A, Mahé B, et al. Preferential amplification of CD8 effector-t cells after transcutaneous application of an inactivated influenza vaccine: a randomized Phase I trial. Kallas EG, ed. PLoS One. 2010;5(5):e10818. doi:10.1371/journal.pone.001081820520820
   PubMed Web of Science ®Google Scholar
• Al-Zahrani S, Zaric M, McCrudden CM, Scott CJ, Kissenpfennig A, Donnelly RF. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv. 2012;9(5):541–550. doi:10.1517/17425247.2012.67603822475249
   PubMed Web of Science ®Google Scholar
• Quan F-S, Kim Y-C, Compans RW, Prausnitz MR, Kang S-M. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release. 2010;147(3):326–332. doi:10.1016/J.JCONREL.2010.07.12520692307
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Chen X, Primiero CA, et al. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release. 2012;159(2):215–221. doi:10.1016/J.JCONREL.2012.01.03022306334
   PubMed Web of Science ®Google Scholar
• Norman JJ, Arya JM, McClain MA, Frew PM, Meltzer MI, Prausnitz MR. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine. 2014;32(16):1856–1862. doi:10.1016/j.vaccine.2014.01.07624530146
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Moffatt K, Alkilani AZ, et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharm Res. 2014;31(8):1989–1999. doi:10.1007/s11095-014-1301-y24549822
   PubMed Web of Science ®Google Scholar
• Lee BY, Bartsch SM, Mvundura M, et al. An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. Vaccine. 2015;33(37):4727–4736. doi:10.1016/j.vaccine.2015.02.07625772675
   PubMed Web of Science ®Google Scholar
• Birchall JC, Clemo R, Anstey A, John DN. Microneedles in clinical practice – an exploratory study into the opinions of healthcare professionals and the public. Pharm Res. 2011;28(1):95–106. doi:10.1007/s11095-010-0101-220238152
   PubMed Web of Science ®Google Scholar
• Marshall S, Sahm LJ, Moore AC. Microneedle technology for immunisation: perception, acceptability and suitability for paediatric use. Vaccine. 2016;34(6):723–734. doi:10.1016/j.vaccine.2015.12.00226706274
   PubMed Web of Science ®Google Scholar
• Vicente-Pérez EM, Quinn HL, McAlister E, et al. The use of a pressure-indicating sensor film to provide feedback upon hydrogel-forming microneedle array self-application in vivo. Pharm Res. 2016;33(12):3072–3080. doi:10.1007/s11095-016-2032-z27633885
   PubMed Web of Science ®Google Scholar
• Gill HS, Prausnitz MR. Does needle size matter? J Diabetes Sci Technol. 2007;1(5):725–729. doi:10.1177/19322968070010051719885141
   PubMedGoogle Scholar
• Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human subjects. Clin J Pain. 2008;24(7):585–594. doi:10.1097/AJP.0b013e31816778f918716497
   PubMed Web of Science ®Google Scholar
• Mooney K, McElnay JC, Donnelly RF. Children’s views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract. 2014;22(5):335–344. doi:10.1111/ijpp.1208124308565
   PubMedGoogle Scholar
• Quinn HL, Hughes CM, Donnelly RF. In vivo and qualitative studies investigating the translational potential of microneedles for use in the older population. Drug Deliv Transl Res. 2018;8(2):307–316. doi:10.1007/s13346-017-0393-428508376
   PubMed Web of Science ®Google Scholar
• Rodgers AM, McCrudden MT, Courtenay AJ, et al. Control of Klebsiella pneumoniae infection in mice using dissolving microarray patches containing gentamicin. Antimicrob Agents Chemother. 2019:1–11. doi:10.1128/AAC.02612-18
   Web of Science ®Google Scholar
• Wedlock PT, Mitgang EA, Elsheikh F, et al. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains. Vaccine. 2019;37(4):645–651. doi:10.1016/J.VACCINE.2018.12.00830578088
   PubMed Web of Science ®Google Scholar
• Hanson CM, George AM, Sawadogo A, Schreiber B. Is freezing in the vaccine cold chain an ongoing issue? A literature review. Vaccine. 2017;35(17):2127–2133. doi:10.1016/J.VACCINE.2016.09.07028364920
   PubMed Web of Science ®Google Scholar
• Kolluru C, Gomaa Y, Prausnitz MR. Development of a thermostable microneedle patch for polio vaccination. Drug Deliv Transl Res. 2019;9(1):192–203. doi:10.1007/s13346-018-00608-930542944
   PubMed Web of Science ®Google Scholar
• Mistilis MJ, Bommarius AS, Prausnitz MR. Development of a thermostable microneedle patch for influenza vaccination. J Pharm Sci. 2015;104(2):740–749. doi:10.1002/jps.2428325448542
   PubMed Web of Science ®Google Scholar
• Mistilis MJ, Joyce JC, Esser ES, et al. Long-term stability of influenza vaccine in a dissolving microneedle patch. Drug Deliv Transl Res. 2017;7(2):195–205. doi:10.1007/s13346-016-0282-226926241
   PubMed Web of Science ®Google Scholar
• Bachy V, Hervouet C, Becker PD, et al. Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci. 2013;110(8):3041–3046. doi:10.1073/pnas.121444911023386724
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR. A microneedle patch containing measles vaccine is immunogenic in non-human primates. Vaccine. 2015;33(37):4712–4718. doi:10.1016/J.VACCINE.2015.02.07425770786
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del Pilar Martin M, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16(8):915–920. doi:10.1038/nm.218220639891
   PubMed Web of Science ®Google Scholar
• Raphael AP, Prow TW, Crichton ML, Chen X, Fernando GJ, Kendall MA. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small. 2010;6(16):1785–1793. doi:10.1002/smll.20100032620665628
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Baudner BC, Oh S, Kwon S, Singh M, O’Hagan DT. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci. 2012;101(3):1021–1027. doi:10.1002/JPS.2301922190403
   PubMed Web of Science ®Google Scholar
• Zhu W, Pewin W, Wang C, et al. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines. J Control Release. 2017;261:1–9. doi:10.1016/j.jconrel.2017.06.01728642154
   PubMed Web of Science ®Google Scholar
• Nakatsukasa A, Kuruma K, Okamatsu M, et al. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice. Vaccine. 2017;35(21):2855–2861. doi:10.1016/j.vaccine.2017.04.00928431812
   PubMed Web of Science ®Google Scholar
• Vassilieva EV, Wang S, Li S, Prausnitz MR, Compans RW. Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine. Sci Rep. 2017;7(1):1–9. doi:10.1038/s41598-017-18140-028127051
   PubMed Web of Science ®Google Scholar
• Deng L, Chang TZ, Wang Y, et al. Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice. Proc Natl Acad Sci. 2018;115(33):E7758–E7767. doi:10.1073/pnas.180571311530065113
   PubMed Web of Science ®Google Scholar
• Littauer EQ, Mills LK, Brock N, et al. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza. J Control Release. 2018;276:1–16. doi:10.1016/j.jconrel.2018.02.03329496540
   PubMed Web of Science ®Google Scholar
• Gala R, Zaman R, D’Souza M, Zughaier S. Novel whole-cell inactivated neisseria gonorrhoeae microparticles as vaccine formulation in microneedle-based transdermal immunization. Vaccines. 2018;6(3):60. doi:10.3390/vaccines6030060
   Web of Science ®Google Scholar
• Chen M-C, Lai K-Y, Ling M-H, Lin C-W. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design. Acta Biomater. 2018;65:66–75. doi:10.1016/j.actbio.2017.11.00429109028
   PubMed Web of Science ®Google Scholar
• Chiu Y-H, Chen M-C, Wan S-W. Sodium hyaluronate/chitosan composite microneedles as a single-dose intradermal immunization system. Biomacromolecules. 2018;19(6):2278–2285. doi:10.1021/acs.biomac.8b0044129722966
   PubMed Web of Science ®Google Scholar
• An M, Liu H. Dissolving microneedle arrays for transdermal delivery of amphiphilic vaccines. Small. 2017;13(26):1–8. doi:10.1002/smll.201700164
   Web of Science ®Google Scholar
• Edens C, Dybdahl-Sissoko NC, Weldon WC, Oberste MS, Prausnitz MR. Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. Vaccine. 2015;33(37):4683–4690. doi:10.1016/j.vaccine.2015.01.08925749246
   PubMed Web of Science ®Google Scholar
• Liao JF, Lee JC, Lin CK, Wei KC, Chen PY, Yang HW. Self-assembly DNA polyplex vaccine inside dissolving microneedles for high-potency intradermal vaccination. Theranostics. 2017;7(10):2593–2605. doi:10.7150/thno.1989428819449
   PubMed Web of Science ®Google Scholar
• Vreman S, McCaffrey J, Popma-de Graaf DJ, et al. Toll-like receptor agonists as adjuvants for inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine. Vet Immunol Immunopathol. 2019;212:27–37. doi:10.1016/j.vetimm.2019.04.00831213249
   PubMed Web of Science ®Google Scholar
• Arya JM, Dewitt K, Scott-Garrard M, Chiang Y-W, Prausnitz MR. Rabies vaccination in dogs using a dissolving microneedle patch. J Control Release. 2016;239:19–26. doi:10.1016/j.jconrel.2016.08.01227524283
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang S, Duan Y, et al. Transcutaneous immunization of recombinant Staphylococcal enterotoxin B protein using a dissolving microneedle provides potent protection against lethal enterotoxin challenge. Vaccine. 2019;37(29):3810–3819. doi:10.1016/j.vaccine.2019.05.05531147275
   PubMed Web of Science ®Google Scholar
• Chen F, Yan Q, Yu Y, Wu MX. BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination. J Control Release. 2017;255:36–44. doi:10.1016/j.jconrel.2017.03.39728390901
   PubMed Web of Science ®Google Scholar
• Yan Q, Cheng ZZ, Liu H, et al. Enhancement of Ag85B DNA vaccine immunogenicity against tuberculosis by dissolving microneedles in mice. Vaccine. 2018;36(30):4471–4476. doi:10.1016/j.vaccine.2018.06.02529910005
   PubMed Web of Science ®Google Scholar
• Matsuo K, Hirobe S, Yokota Y, et al. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. J Control Release. 2012;160(3):495–501. doi:10.1016/J.JCONREL.2012.04.00122516091
   PubMed Web of Science ®Google Scholar
• Matsuo K, Okamoto H, Kawai Y, et al. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer’s disease. J Neuroimmunol. 2014;266(1–2):1–11. doi:10.1016/J.JNEUROIM.2013.11.00224315156
   PubMed Web of Science ®Google Scholar
• Zhu Z, Ye X, Ku Z, et al. Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by enterovirus 71. J Control Release. 2016;243:291–302. doi:10.1016/J.JCONREL.2016.10.01927793685
   PubMed Web of Science ®Google Scholar
• Poirier D, Renaud F, Dewar V, et al. Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable. Biomaterials. 2017;145:256–265. doi:10.1016/j.biomaterials.2017.08.03828915391
   PubMed Web of Science ®Google Scholar
• Pattani A, McKay PF, Garland MJ, et al. Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. J Control Release. 2012;162(3):529–537. doi:10.1016/j.jconrel.2012.07.03922960496
   PubMed Web of Science ®Google Scholar
• Esser ES, Romanyuk AA, Vassilieva EV, et al. Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy. J Control Release. 2016;236:47–56. doi:10.1016/j.jconrel.2016.06.02627327766
   PubMed Web of Science ®Google Scholar
• Chu LY, Ye L, Dong K, Compans RW, Yang C, Prausnitz MR. Enhanced stability of inactivated influenza vaccine encapsulated in dissolving microneedle patches. Pharm Res. 2016;33(4):868–878. doi:10.1007/s11095-015-1833-926620313
   PubMed Web of Science ®Google Scholar
• Hirobe S, Azukizawa H, Hanafusa T, et al. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials. 2015;57:50–58. doi:10.1016/j.biomaterials.2015.04.00725913250
   PubMed Web of Science ®Google Scholar
• Zaric M, Lyubomska O, Poux C, et al. Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and th1 immune responses by murine langerhans cells. J Invest Dermatol. 2015;135(2):425–434. doi:10.1038/jid.2014.41525243789
   PubMed Web of Science ®Google Scholar
• Mönkäre J, Reza Nejadnik M, Baccouche K, Romeijn SG, Jiskoot W, Bouwstra JA. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery. J Control Release. 2015;218:53–62. doi:10.1016/j.jconrel.2015.10.00226437262
   PubMed Web of Science ®Google Scholar
• Leone M, Priester MI, Romeijn S, et al. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: formulation, physicochemical characterization and immunogenicity assessment. Eur J Pharm Biopharm. 2019;134:49–59. doi:10.1016/j.ejpb.2018.11.01330453025
   PubMed Web of Science ®Google Scholar
• Lee JW, Prausnitz MR. Drug delivery using microneedle patches: not just for skin. Expert Opin Drug Deliv. 2018;15(6):541–543. doi:10.1080/17425247.2018.147105929708770
   PubMed Web of Science ®Google Scholar
• Wang N, Zhen Y, Jin Y, et al. Combining different types of multifunctional liposomes loaded with ammonium bicarbonate to fabricate microneedle arrays as a vaginal mucosal vaccine adjuvant-dual delivery system (VADDS). J Control Release. 2017;246:12–29. doi:10.1016/J.JCONREL.2016.12.00927986552
   PubMed Web of Science ®Google Scholar
• Ma Y, Tao W, Krebs SJ, Sutton WF, Haigwood NL, Gill HS. Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity. Pharm Res. 2014;31(9):2393–2403. doi:10.1007/s11095-014-1335-124623480
   PubMed Web of Science ®Google Scholar
• González García LE, MacGregor MN, Visalakshan RM, et al. Self-sterilizing antibacterial silver-loaded microneedles. Chem Commun. 2019;55(2):171–174. doi:10.1039/C8CC06035E
   Web of Science ®Google Scholar
• McCrudden MT, Alkilani AZ, Courtenay AJ, et al. Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res. 2014;5(1):3–14. doi:10.1007/s13346-014-0211-1
   Web of Science ®Google Scholar
• Donnelly RF, Singh TRR, Alkilani AZ, et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int J Pharm. 2013;451(1–2):76–91. doi:10.1016/j.ijpharm.2013.04.04523644043
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Singh TRR, Tunney MM, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res. 2009;26(11):2513–2522. doi:10.1007/s11095-009-9967-219756972
   PubMed Web of Science ®Google Scholar
• Vicente-Pérez EM, Larrañeta E, McCrudden MT, et al. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo. Eur J Pharm Biopharm. 2017;117:400–407. doi:10.1016/j.ejpb.2017.04.02928478160
   PubMed Web of Science ®Google Scholar
• Wei-Ze L, Mei-Rong H, Jian-Ping Z, et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int J Pharm. 2010;389(1–2):122–129. doi:10.1016/j.ijpharm.2010.01.02420096759
   PubMed Web of Science ®Google Scholar
• Leone M, Mönkäre J, Bouwstra JA, Kersten GF. Dissolving microneedle patches for dermal vaccination. Pharm Res. 2017;34(11):2223–2240. doi:10.1007/s11095-017-2223-228718050
   PubMed Web of Science ®Google Scholar
• Quinn HL, Larrañeta E, Donnelly RF. Dissolving microneedles: safety considerations and future perspectives. Ther Deliv. 2016;7(5):283–285. doi:10.4155/tde.14.8227075949
   PubMedGoogle Scholar
• Nair B. Final report on the safety assessment of polyvinylpyrrolidone (PVP). Int J Toxicol. 1998;17(4_suppl):95–130. doi:10.1177/109158189801700408
   Google Scholar
• Indermun S, Luttge R, Choonara YE, et al. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014;185:130–138. doi:10.1016/j.jconrel.2014.04.05224806483
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207. doi:10.3109/1071754100366779820297904
   PubMed Web of Science ®Google Scholar
• Kennedy J, Larrañeta E, McCrudden MT, et al. In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles. J Control Release. 2017;265:57–65. doi:10.1016/j.jconrel.2017.04.02228428065
   PubMed Web of Science ®Google Scholar
• Chu LY, Choi S-O, Prausnitz MR. Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs. J Pharm Sci. 2010;99(10):4228–4238. doi:10.1002/jps.2214020737630
   PubMed Web of Science ®Google Scholar
• Lutton RE, Moore J, Larrañeta E, Ligett S, Woolfson AD, Donnelly RF. Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res. 2015;5(4):313–331. doi:10.1007/s13346-015-0237-z26022578
   PubMed Web of Science ®Google Scholar
• Park JH, Choi SO, Seo S, Bin CY, Prausnitz MR. A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm. 2010;76(2):282–289. doi:10.1016/j.ejpb.2010.07.00120624460
   PubMed Web of Science ®Google Scholar
• Leone M, van Oorschot BH, Nejadnik MR, et al. Universal applicator for digitally-controlled pressing force and impact velocity insertion of microneedles into skin. Pharmaceutics. 2018;10(4). doi:10.3390/pharmaceutics10040211
   Web of Science ®Google Scholar
• Singh TR, Dunne NJ, Cunningham E, Donnelly RF. Review of patents on microneedle applicators. Recent Pat Drug Deliv Formul. 2011;5(1):11–23.21143128
   PubMedGoogle Scholar
• Sausse Lhernould M, Delchambre A. Innovative design of hollow polymeric microneedles for transdermal drug delivery. Microsyst Technol. 2011;17(10–11):1675–1682. doi:10.1007/s00542-011-1355-2
   Web of Science ®Google Scholar
• Leone M, Mönkäre J, Bouwstra JA, Kersten GF. Dissolving Microneedle Patches for Dermal Vaccination. Pharm Res. 2017;34(11):2223–2240. doi:10.1007/s11095-017-2223-228718050
   PubMed Web of Science ®Google Scholar